TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Biosimilar Testing and Development Services Market Insights, Forecast to 2028

Global Biosimilar Testing and Development Services Market Insights, Forecast to 2028

  • Category:Life Sciences
  • Published on : 14 June 2022
  • Pages :106
  • Formats:
  • Report Code:SMR-7149384
OfferClick for best price

Best Price: $3920

Biosimilar Testing Development Services Market Size, Share 2022


Market Analysis and Insights: Global Biosimilar Testing Development Services Market

The global Biosimilar Testing Development Services market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biosimilar Testing Development Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biosimilar Testing Development Services market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biosimilar Testing Development Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biosimilar Testing Development Services market.

Global Biosimilar Testing Development Services Scope and Market Size

Biosimilar Testing and Development Services market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Biosimilar Testing and Development Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Effector Binding

ELISA

Kinetic Binding Assays

ADCC & CDC Cell-Based Assays

Segment by Application

PK assay

Tiered Immunogenicity testing

NAb assays

By Company

Eurofins Scientific

SGS

Charles River Laboratories

Pharmaceutical Product Development

Exova

Source BioScience

Intertek Group

Medistri

Pace Analytical Services

Sigma-Aldrich

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Biosimilar Testing Development Services product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Biosimilar Testing Development Services, with price, sales, revenue, and global market share of Biosimilar Testing Development Services from 2019 to 2022.

Chapter 3, the Biosimilar Testing Development Services competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Biosimilar Testing Development Services breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Biosimilar Testing Development Services market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Biosimilar Testing Development Services.

Chapter 13, 14, and 15, to describe Biosimilar Testing Development Services sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Biosimilar Testing Development Services Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Biosimilar Testing and Development Services Market Insights, Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 106 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilar Testing and Development Services Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Effector Binding
1.2.3 ELISA
1.2.4 Kinetic Binding Assays
1.2.5 ADCC & CDC Cell-Based Assays
1.3 Market by Application
1.3.1 Global Biosimilar Testing and Development Services Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 PK assay
1.3.3 Tiered Immunogenicity testing
1.3.4 NAb assays
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biosimilar Testing and Development Services Market Perspective (2017-2028)
2.2 Biosimilar Testing and Development Services Growth Trends by Region
2.2.1 Biosimilar Testing and Development Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biosimilar Testing and Development Services Historic Market Size by Region (2017-2022)
2.2.3 Biosimilar Testing and Development Services Forecasted Market Size by Region (2023-2028)
2.3 Biosimilar Testing and Development Services Market Dynamics
2.3.1 Biosimilar Testing and Development Services Industry Trends
2.3.2 Biosimilar Testing and Development Services Market Drivers
2.3.3 Biosimilar Testing and Development Services Market Challenges
2.3.4 Biosimilar Testing and Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilar Testing and Development Services Players by Revenue
3.1.1 Global Top Biosimilar Testing and Development Services Players by Revenue (2017-2022)
3.1.2 Global Biosimilar Testing and Development Services Revenue Market Share by Players (2017-2022)
3.2 Global Biosimilar Testing and Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biosimilar Testing and Development Services Revenue
3.4 Global Biosimilar Testing and Development Services Market Concentration Ratio
3.4.1 Global Biosimilar Testing and Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Testing and Development Services Revenue in 2021
3.5 Biosimilar Testing and Development Services Key Players Head office and Area Served
3.6 Key Players Biosimilar Testing and Development Services Product Solution and Service
3.7 Date of Enter into Biosimilar Testing and Development Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilar Testing and Development Services Breakdown Data by Type
4.1 Global Biosimilar Testing and Development Services Historic Market Size by Type (2017-2022)
4.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2023-2028)
5 Biosimilar Testing and Development Services Breakdown Data by Application
5.1 Global Biosimilar Testing and Development Services Historic Market Size by Application (2017-2022)
5.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biosimilar Testing and Development Services Market Size (2017-2028)
6.2 North America Biosimilar Testing and Development Services Market Size by Type
6.2.1 North America Biosimilar Testing and Development Services Market Size by Type (2017-2022)
6.2.2 North America Biosimilar Testing and Development Services Market Size by Type (2023-2028)
6.2.3 North America Biosimilar Testing and Development Services Market Share by Type (2017-2028)
6.3 North America Biosimilar Testing and Development Services Market Size by Application
6.3.1 North America Biosimilar Testing and Development Services Market Size by Application (2017-2022)
6.3.2 North America Biosimilar Testing and Development Services Market Size by Application (2023-2028)
6.3.3 North America Biosimilar Testing and Development Services Market Share by Application (2017-2028)
6.4 North America Biosimilar Testing and Development Services Market Size by Country
6.4.1 North America Biosimilar Testing and Development Services Market Size by Country (2017-2022)
6.4.2 North America Biosimilar Testing and Development Services Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Biosimilar Testing and Development Services Market Size (2017-2028)
7.2 Europe Biosimilar Testing and Development Services Market Size by Type
7.2.1 Europe Biosimilar Testing and Development Services Market Size by Type (2017-2022)
7.2.2 Europe Biosimilar Testing and Development Services Market Size by Type (2023-2028)
7.2.3 Europe Biosimilar Testing and Development Services Market Share by Type (2017-2028)
7.3 Europe Biosimilar Testing and Development Services Market Size by Application
7.3.1 Europe Biosimilar Testing and Development Services Market Size by Application (2017-2022)
7.3.2 Europe Biosimilar Testing and Development Services Market Size by Application (2023-2028)
7.3.3 Europe Biosimilar Testing and Development Services Market Share by Application (2017-2028)
7.4 Europe Biosimilar Testing and Development Services Market Size by Country
7.4.1 Europe Biosimilar Testing and Development Services Market Size by Country (2017-2022)
7.4.2 Europe Biosimilar Testing and Development Services Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosimilar Testing and Development Services Market Size (2017-2028)
8.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Type
8.2.1 Asia-Pacific Biosimilar Testing and Development Services Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Biosimilar Testing and Development Services Market Share by Type (2017-2028)
8.3 Asia-Pacific Biosimilar Testing and Development Services Market Size by Application
8.3.1 Asia-Pacific Biosimilar Testing and Development Services Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Biosimilar Testing and Development Services Market Share by Application (2017-2028)
8.4 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region
8.4.1 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biosimilar Testing and Development Services Market Size (2017-2028)
9.2 Latin America Biosimilar Testing and Development Services Market Size by Type
9.2.1 Latin America Biosimilar Testing and Development Services Market Size by Type (2017-2022)
9.2.2 Latin America Biosimilar Testing and Development Services Market Size by Type (2023-2028)
9.2.3 Latin America Biosimilar Testing and Development Services Market Share by Type (2017-2028)
9.3 Latin America Biosimilar Testing and Development Services Market Size by Application
9.3.1 Latin America Biosimilar Testing and Development Services Market Size by Application (2017-2022)
9.3.2 Latin America Biosimilar Testing and Development Services Market Size by Application (2023-2028)
9.3.3 Latin America Biosimilar Testing and Development Services Market Share by Application (2017-2028)
9.4 Latin America Biosimilar Testing and Development Services Market Size by Country
9.4.1 Latin America Biosimilar Testing and Development Services Market Size by Country (2017-2022)
9.4.2 Latin America Biosimilar Testing and Development Services Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosimilar Testing and Development Services Market Size (2017-2028)
10.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Type
10.2.1 Middle East & Africa Biosimilar Testing and Development Services Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Biosimilar Testing and Development Services Market Share by Type (2017-2028)
10.3 Middle East & Africa Biosimilar Testing and Development Services Market Size by Application
10.3.1 Middle East & Africa Biosimilar Testing and Development Services Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Biosimilar Testing and Development Services Market Share by Application (2017-2028)
10.4 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country
10.4.1 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Details
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Biosimilar Testing and Development Services Introduction
11.1.4 Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2017-2022)
11.1.5 Eurofins Scientific Recent Developments
11.2 SGS
11.2.1 SGS Company Details
11.2.2 SGS Business Overview
11.2.3 SGS Biosimilar Testing and Development Services Introduction
11.2.4 SGS Revenue in Biosimilar Testing and Development Services Business (2017-2022)
11.2.5 SGS Recent Developments
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Details
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Biosimilar Testing and Development Services Introduction
11.3.4 Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2017-2022)
11.3.5 Charles River Laboratories Recent Developments
11.4 Pharmaceutical Product Development
11.4.1 Pharmaceutical Product Development Company Details
11.4.2 Pharmaceutical Product Development Business Overview
11.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Introduction
11.4.4 Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2017-2022)
11.4.5 Pharmaceutical Product Development Recent Developments
11.5 Exova
11.5.1 Exova Company Details
11.5.2 Exova Business Overview
11.5.3 Exova Biosimilar Testing and Development Services Introduction
11.5.4 Exova Revenue in Biosimilar Testing and Development Services Business (2017-2022)
11.5.5 Exova Recent Developments
11.6 Source BioScience
11.6.1 Source BioScience Company Details
11.6.2 Source BioScience Business Overview
11.6.3 Source BioScience Biosimilar Testing and Development Services Introduction
11.6.4 Source BioScience Revenue in Biosimilar Testing and Development Services Business (2017-2022)
11.6.5 Source BioScience Recent Developments
11.7 Intertek Group
11.7.1 Intertek Group Company Details
11.7.2 Intertek Group Business Overview
11.7.3 Intertek Group Biosimilar Testing and Development Services Introduction
11.7.4 Intertek Group Revenue in Biosimilar Testing and Development Services Business (2017-2022)
11.7.5 Intertek Group Recent Developments
11.8 Medistri
11.8.1 Medistri Company Details
11.8.2 Medistri Business Overview
11.8.3 Medistri Biosimilar Testing and Development Services Introduction
11.8.4 Medistri Revenue in Biosimilar Testing and Development Services Business (2017-2022)
11.8.5 Medistri Recent Developments
11.9 Pace Analytical Services
11.9.1 Pace Analytical Services Company Details
11.9.2 Pace Analytical Services Business Overview
11.9.3 Pace Analytical Services Biosimilar Testing and Development Services Introduction
11.9.4 Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2017-2022)
11.9.5 Pace Analytical Services Recent Developments
11.10 Sigma-Aldrich
11.10.1 Sigma-Aldrich Company Details
11.10.2 Sigma-Aldrich Business Overview
11.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Introduction
11.10.4 Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2017-2022)
11.10.5 Sigma-Aldrich Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Biosimilar Testing and Development Services Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Effector Binding
Table 3. Key Players of ELISA
Table 4. Key Players of Kinetic Binding Assays
Table 5. Key Players of ADCC & CDC Cell-Based Assays
Table 6. Global Biosimilar Testing and Development Services Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Biosimilar Testing and Development Services Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Biosimilar Testing and Development Services Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Biosimilar Testing and Development Services Market Share by Region (2017-2022)
Table 10. Global Biosimilar Testing and Development Services Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Biosimilar Testing and Development Services Market Share by Region (2023-2028)
Table 12. Biosimilar Testing and Development Services Market Trends
Table 13. Biosimilar Testing and Development Services Market Drivers
Table 14. Biosimilar Testing and Development Services Market Challenges
Table 15. Biosimilar Testing and Development Services Market Restraints
Table 16. Global Biosimilar Testing and Development Services Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Biosimilar Testing and Development Services Revenue Share by Players (2017-2022)
Table 18. Global Top Biosimilar Testing and Development Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Testing and Development Services as of 2021)
Table 19. Ranking of Global Top Biosimilar Testing and Development Services Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Biosimilar Testing and Development Services Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Biosimilar Testing and Development Services Product Solution and Service
Table 23. Date of Enter into Biosimilar Testing and Development Services Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biosimilar Testing and Development Services Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2017-2022)
Table 27. Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2023-2028)
Table 29. Global Biosimilar Testing and Development Services Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Biosimilar Testing and Development Services Revenue Share by Application (2017-2022)
Table 31. Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Biosimilar Testing and Development Services Revenue Share by Application (2023-2028)
Table 33. North America Biosimilar Testing and Development Services Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Biosimilar Testing and Development Services Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Biosimilar Testing and Development Services Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Biosimilar Testing and Development Services Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Biosimilar Testing and Development Services Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Biosimilar Testing and Development Services Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Biosimilar Testing and Development Services Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Biosimilar Testing and Development Services Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Biosimilar Testing and Development Services Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Biosimilar Testing and Development Services Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Biosimilar Testing and Development Services Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Biosimilar Testing and Development Services Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Biosimilar Testing and Development Services Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Biosimilar Testing and Development Services Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Biosimilar Testing and Development Services Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Biosimilar Testing and Development Services Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Biosimilar Testing and Development Services Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Biosimilar Testing and Development Services Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Biosimilar Testing and Development Services Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Biosimilar Testing and Development Services Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Biosimilar Testing and Development Services Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Biosimilar Testing and Development Services Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Biosimilar Testing and Development Services Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Biosimilar Testing and Development Services Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Biosimilar Testing and Development Services Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Biosimilar Testing and Development Services Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Biosimilar Testing and Development Services Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Biosimilar Testing and Development Services Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Biosimilar Testing and Development Services Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Biosimilar Testing and Development Services Market Size by Country (2023-2028) & (US$ Million)
Table 63. Eurofins Scientific Company Details
Table 64. Eurofins Scientific Business Overview
Table 65. Eurofins Scientific Biosimilar Testing and Development Services Product
Table 66. Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
Table 67. Eurofins Scientific Recent Developments
Table 68. SGS Company Details
Table 69. SGS Business Overview
Table 70. SGS Biosimilar Testing and Development Services Product
Table 71. SGS Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
Table 72. SGS Recent Developments
Table 73. Charles River Laboratories Company Details
Table 74. Charles River Laboratories Business Overview
Table 75. Charles River Laboratories Biosimilar Testing and Development Services Product
Table 76. Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
Table 77. Charles River Laboratories Recent Developments
Table 78. Pharmaceutical Product Development Company Details
Table 79. Pharmaceutical Product Development Business Overview
Table 80. Pharmaceutical Product Development Biosimilar Testing and Development Services Product
Table 81. Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
Table 82. Pharmaceutical Product Development Recent Developments
Table 83. Exova Company Details
Table 84. Exova Business Overview
Table 85. Exova Biosimilar Testing and Development Services Product
Table 86. Exova Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
Table 87. Exova Recent Developments
Table 88. Source BioScience Company Details
Table 89. Source BioScience Business Overview
Table 90. Source BioScience Biosimilar Testing and Development Services Product
Table 91. Source BioScience Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
Table 92. Source BioScience Recent Developments
Table 93. Intertek Group Company Details
Table 94. Intertek Group Business Overview
Table 95. Intertek Group Biosimilar Testing and Development Services Product
Table 96. Intertek Group Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
Table 97. Intertek Group Recent Developments
Table 98. Medistri Company Details
Table 99. Medistri Business Overview
Table 100. Medistri Biosimilar Testing and Development Services Product
Table 101. Medistri Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
Table 102. Medistri Recent Developments
Table 103. Pace Analytical Services Company Details
Table 104. Pace Analytical Services Business Overview
Table 105. Pace Analytical Services Biosimilar Testing and Development Services Product
Table 106. Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
Table 107. Pace Analytical Services Recent Developments
Table 108. Sigma-Aldrich Company Details
Table 109. Sigma-Aldrich Business Overview
Table 110. Sigma-Aldrich Biosimilar Testing and Development Services Product
Table 111. Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
Table 112. Sigma-Aldrich Recent Developments
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosimilar Testing and Development Services Market Share by Type: 2021 VS 2028
Figure 2. Effector Binding Features
Figure 3. ELISA Features
Figure 4. Kinetic Binding Assays Features
Figure 5. ADCC & CDC Cell-Based Assays Features
Figure 6. Global Biosimilar Testing and Development Services Market Share by Application: 2021 VS 2028
Figure 7. PK assay Case Studies
Figure 8. Tiered Immunogenicity testing Case Studies
Figure 9. NAb assays Case Studies
Figure 10. Biosimilar Testing and Development Services Report Years Considered
Figure 11. Global Biosimilar Testing and Development Services Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Biosimilar Testing and Development Services Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Biosimilar Testing and Development Services Market Share by Region: 2021 VS 2028
Figure 14. Global Biosimilar Testing and Development Services Market Share by Players in 2021
Figure 15. Global Top Biosimilar Testing and Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Testing and Development Services as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Biosimilar Testing and Development Services Revenue in 2021
Figure 17. North America Biosimilar Testing and Development Services Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Biosimilar Testing and Development Services Market Size Market Share by Type (2017-2028)
Figure 19. North America Biosimilar Testing and Development Services Market Size Market Share by Application (2017-2028)
Figure 20. North America Biosimilar Testing and Development Services Market Size Share by Country (2017-2028)
Figure 21. United States Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Biosimilar Testing and Development Services Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Biosimilar Testing and Development Services Market Size Market Share by Type (2017-2028)
Figure 25. Europe Biosimilar Testing and Development Services Market Size Market Share by Application (2017-2028)
Figure 26. Europe Biosimilar Testing and Development Services Market Size Share by Country (2017-2028)
Figure 27. Germany Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Biosimilar Testing and Development Services Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Biosimilar Testing and Development Services Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Biosimilar Testing and Development Services Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Biosimilar Testing and Development Services Market Size Share by Region (2017-2028)
Figure 37. China Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Biosimilar Testing and Development Services Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Biosimilar Testing and Development Services Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Biosimilar Testing and Development Services Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Biosimilar Testing and Development Services Market Size Share by Country (2017-2028)
Figure 47. Mexico Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Biosimilar Testing and Development Services Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Biosimilar Testing and Development Services Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Biosimilar Testing and Development Services Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Biosimilar Testing and Development Services Market Size Share by Country (2017-2028)
Figure 53. Turkey Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Eurofins Scientific Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
Figure 57. SGS Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
Figure 58. Charles River Laboratories Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
Figure 59. Pharmaceutical Product Development Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
Figure 60. Exova Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
Figure 61. Source BioScience Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
Figure 62. Intertek Group Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
Figure 63. Medistri Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
Figure 64. Pace Analytical Services Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
Figure 65. Sigma-Aldrich Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount